Results 141 to 150 of about 31,524 (206)

Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension. [PDF]

open access: yesNat Commun
Nordbeck P   +21 more
europepmc   +1 more source

Molecular Variations in Glycoprotein B of Asian Human Cytomegalovirus: Potential Impact on Virus Entry and Immune Evasion in Ocular Diseases. [PDF]

open access: yesJ Med Virol
Lestari T   +28 more
europepmc   +1 more source

A novel SadP-scFv UCHT1 lectibody activates T cells and mediates lysis of Burkitt's lymphoma cells. [PDF]

open access: yesRSC Chem Biol
Tomisch J   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy